Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer

Christina Pappa & Mo'iad Alazzam et al. · 2024-06-27

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of secondary CRS and chemotherapy in comparison to chemotherapy alone for women with platinum-sensitive recurrent epithelial ovarian cancer.
Authors
Christina Pappa, Khadra Galaal, Sarah Smyth, Robert E Bristow, Ali S Khashan, Mo'iad Alazzam